Pathogenesis (development of disease)
Approximately 99% of magnesium in the body is intracellular (“inside the cell”). Thus, measurement of magnesium in serum does not optimally represent magnesium balance. Magnesium distribution:
- 50-65% = freely ionizing form of magnesium.
- 20 % = Mg2+ bound to plasma protein
- 20-25 % = Mg2+ forms complexes with phosphate, oxalate and other anions.
In the majority of cases, hypomagnesemia is due to inadequate magnesium intake and renal (kidney-related) magnesium losses; more rarely, enteric (intestinal) magnesium losses are present. Where this condition is clearly attributable to a disease, it is indicated below.
Etiology (causes)
Biographic causes
- Genetic burden/disease
- Familial hypomagnesemia with hypercalciuria (increased excretion of calcium in the urine) and consecutive nephrocalcinosis (deposition of calcium salts in the parenchyma of the kidney) due to a mutation in the paracellin-1 gene
- Gitelman syndrome – genetic condition leading to increased loss of potassium and magnesium through the kidney.
Behavioral causes
- Nutrition
- Micronutrient deficiency (vital substances) – see Prevention with micronutrients: Hypomagnesemia
- Consumption of stimulants
Disease-related causes
Endocrine, nutritional and metabolic diseases (E00-E90).
- Diabetes mellitus type 1/type 2 (glucosuria) [renal magnesium loss].
- Hyperaldosteronism [renal magnesium loss]
- Hypercalcemia [renal magnesium loss due to inhibition of tubular magnesium reabsorption]
- Hyperthyroidism (e.g., Graves’ disease) [renal magnesium loss]
- Hypoparathyroidism (parathyroid hypofunction) [renal magnesium loss]
- Malnutrition
- Metabolic acidosis (metabolic acidosis) [renal magnesium loss].
Infectious and parasitic diseases (A00-B99).
- Infectious gastroenteritis (gastroenteritis), unspecified.
Liver, gallbladder, and biliary tract-pancreas (pancreas) (K70-K77; K80-K87).
- Acute pancreatitis (inflammation of the pancreas).
Mouth, esophagus (esophagus), stomach, and intestines (K00-K67; K90-K93).
- Ulcerative colitis – chronic inflammatory disease of the mucosa of the colon or rectum.
- Malassimilation syndrome – complex of symptoms of different genesis (origin) as a result of malabsorption (Latin “poor absorption“), maldigestion (decreased utilization of nutrients) or the combination of both symptoms.
- Crohn’s disease – chronic inflammatory bowel disease; it usually runs in relapses and can affect the entire digestive tract; characteristic is the segmental affection of the intestinal mucosa (intestinal mucosa), that is, it may be affected several intestinal segments that are separated by healthy sections from each other
- Non-infectious gastroenteritis, unspecified.
- Celiac disease (synonyms: celiac disease; coeliac disease; indigenous sprue; gluten allergy; gluten-induced enteropathy; gluten-sensitive enteropathy; gluten intolerance) – chronic disease of the small intestinal mucosa due to hypersensitivity to the cereal protein gluten.
Psyche – nervous system (F00-F99; G00-G99).
Symptoms and abnormal clinical and laboratory findings not elsewhere classified (R00-R99).
- Diarrhea (diarrhea)
Other causes
- Enteral fistulas
- Enterostomy (artificial bowel outlet)
- Parenteral nutrition (“bypassing the intestine”) without added magnesium.
Medication
- Antibiotics
- Aminoglycosides (amikacin, apramycin, geneticin (G418), gentamicin, kanamycin, netilmicin, neomycin, paromomycin, spectinomycin, streptomycin, tobramycin).
- Antiprotozoal
- Pentamidine
- Diuretics
- Loop diuretics (etacrynic acid, furosemide, piretanide, torasemide), thiazide diuretics (chlortalidone, hydrochlorothiazide (HCT), xipamide).
- Thiazide diuretics (chlortalidone, hydrochlorothiazide (HCT), xipamide).
- Immunosuppressants (ciclosporin (cyclosporin A))
- Proton pump inhibitors (proton pump inhibitors, PPI) – esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole [continuous therapy].
- Cytostatic drugs (cisplatin)
Note: For literature on the topic of risk groups of magnesium deficiency, see “Micronutrient Medicine/Magnesium/Risk Groups”.